$Orchestra BioMed(OBIO.US)$The FDA Granted An Investigational Device Exemption To Initiate BACKBEAT Study Evaluating Orchestra Biomed's Atrioventricular Interval Modulation Therapy (BACKBEAT CNT) For Hypertensive Patients Who Are Indicated For A Dual-chamber Cardiac Pacemaker
Rivera : 不錯移動
SoCalCommish760樓主 Rivera: 你覺得怎麼樣?
Rivera SoCalCommish760樓主: 查看十一至十五